NCT04980807View on ClinicalTrials.gov

Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 7, 2021

Primary Completion Date

March 3, 2022

Study Completion Date

March 3, 2022

Conditions
Charcot-Marie-Tooth Disease
Trial Locations (2)

8200

Aarhus University Hospital, Aarhus

43210

Ohio State University, Columbus

Sponsors

Lead Sponsor

NMD Pharma A/S
All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Ohio State University

OTHER

lead

NMD Pharma A/S

INDUSTRY

NCT04980807 - Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls | Biotech Hunter | Biotech Hunter